BioSpace News Archive

Biotech Bay

Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results to three years.

April 8, 2024
·
6 min read
Business

Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.

April 8, 2024
·
1 min read
Bio NC

IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud

IQVIA and Salesforce announced an expanded global strategic partnership to accelerate the development of Salesforce’s Life Sciences Cloud, a next-generation customer engagement platform for the global life sciences industry.

April 8, 2024
·
4 min read
CASI Pharmaceuticals Reports Development Relating to Its Disputes With Juventas

CASI Pharmaceuticals, Inc. reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas.

April 8, 2024
·
5 min read
Cantargia presents unique effects of nadunolimab in pancreatic cancer

Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented new preclinical data for its lead candidate, the IL1RAP-binding antibody nadunolimab (CAN04) at the AACR Annual Meeting.

April 8, 2024
·
4 min read